The absence of IL-30 in the host environment might slow down tumor growth by preventing Treg expansion and immunosuppressive functions, and by skewing the cytokine milieu towards a Th1-type, IFNγ- and IL-12-driven, immune response. Here, IL27 is linked to neoplasm.